Boston Scientific Newsroom

Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Announces Target Price $110

Futu News21:31 · Ratings

Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex

Yahoo Finance19:48

Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know

Yahoo Finance07:00

Morgan Stanley Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100

Futu NewsDec 17 09:31 · Ratings

Optimistic Outlook for Boston Scientific's Urology Segment Drives Buy Recommendation

TipRanksDec 17 08:55

FDA Roundup: December 17, 2024

US FDADec 17 08:00

JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $110

BenzingaDec 17 00:51 · Ratings

FDA Alerting About Potential Need For Early Device Replacement Of Boston Scientific Accolade Pacemaker Devices; Boston Scientific Announced Recall For Subset Of Accolade Pacemaker Devices With Increased Risk To Permanently Enter Safety Mode

BenzingaDec 17 00:25

Goldman Sachs Raises Price Target on Boston Scientific to $103 From $102, Maintains Buy Rating

MT NewswiresDec 16 20:03 · Ratings

Investing in Boston Scientific (NYSE:BSX) Three Years Ago Would Have Delivered You a 121% Gain

Yahoo FinanceDec 15 22:00

Jim Cramer on Boston Scientific Corporation (BSX): 'A Superior Company'

Yahoo FinanceDec 14 12:10

Boston Scientific Is Maintained at Buy by TD Cowen

Dow JonesDec 13 02:08 · Ratings

Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes

Zacks Dec 12 21:30

Market Mania Won't Last. Buy These 8 Stocks to Weather the Storm, Analyst Says.

BarronsDec 12 19:55

TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $110

Futu NewsDec 12 19:31 · Ratings

TD Cowen Adjusts Price Target on Boston Scientific to $110 From $100, Maintains Buy Rating

MT NewswiresDec 12 18:54 · Ratings

Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note

Yahoo FinanceDec 12 07:00

Unusual Options Activity: CVS, BSX and Others Attract Market Bets, CVS V/OI Ratio Reaches 405.0

EST Dec 11th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options

Futu NewsDec 12 05:30

Boston Scientific Is Maintained at Overweight by Wells Fargo

Dow JonesDec 11 23:16 · Ratings

Express News | Boston Scientific Cmo Discuss Solutions for Health Inequality on Today's Marketplace

BreakingsDec 11 21:08